The potential multibillion-dollar deal between IBM and Sun Microsystems may have been put on ice because of a disagreement between the companies' board of directors. Steve Henn reports who went cold in the deal.

Regulators in China have denied Coca-Cola's plan to buy a Chinese juice company. Dan Grech reports the broken deal may signal rising protectionism in China and worldwide.

Sun Microsystems and IBM are reportedly in talks over a potential $6.5 billion merger deal. Janet Babin explores what the two tech companies have in common and how the deal could help Sun Microsystems gain an edge over competition.

People are cutting back on a lot of things in this downturn, but not on pet needs. That may be one reason why meat producer Tyson Foods is partnering with Freshpet to enter the pet food business. Caitlan Carroll reports.

Swiss drug maker Roche is acquiring U.S. biotech giant Genentech in a $47 billion deal. Sam Eaton reports on the latest example of a pharmaceutical company buying out a competitor to boost its product line.

Drug makers Merck and Schering-Plough will join forces under Merck's name in a deal worth $41 billion in cash and stock. Steve Chiotakis talks to Ashley Milne-Tyte about how both companies stand to benefit from the deal.

Pfizer announced a deal this morning to buy Wyeth for more than $68 billion, which it will do with the help of bailed-out banks. What does this say about the lending health of these banks? Steve Henn reports.

Dubai investors who bought Barneys New York less than two years ago now want to put it up for sale. Sovereign wealth funds like Dubai's were once huge sources of cash for U.S. companies. But that's starting to change. Sam Eaton reports.

Reports out this morning say mega pharmaceutical company Pfizer is in talks to buy competitor Wyeth in a potential $60 billion deal. Pfizer may be considering the move because it's running out of options. Ashley Milne-Tyte reports.